Research and Markets (http://www.researchandmarkets.com/research/cfb25d/2009_cro_quality_b)
has announced the addition of the "2009
CRO Quality Benchmarking Study - CRO Selection for Biotechnology
Companies" report to their offering.
This is a substantial study based on interviews with 44 biotechnology
company representatives, rating 130 unique projects with CROs.
Respondents graded 10 prominent service providers across 18 important
capabilities that affect provider selection and delivery quality. The
report contains 139 pages, including 138 charts and graphs, and in-depth
analysis not previously available to the industry.
This study - designed, executed and analyzed by research professionals
from the pharma services industry - is the first ever "Consumer Reports"
style guide to buying and delivering quality product development
services.
Service buyers can rely on this report to substantially inform their
selection of development partners that best fit their unique needs.
Service providers can rely on this report to provide them with clear
service enhancement recommendations and opportunities to differentiate
themselves from the crowded market of CROs.
Key Topics Covered:
Executive Summary
-
Implications for Biotech Companies
-
Implications for Service Providers
Study Methodology
Market Dynamics and Selection Criteria
-
Outsourcing Volume
-
Service Provider Leadership
-
Service Provider Usage Trends
-
Service Provider Selection Criteria
Service Provider Quality, Performance, and Perceptions
-
Service Provider Report Cards
-
Segment Selection Rubrics and CROs to Short List
-
Management
-
Independence
-
Benchmarking Service Provider Performance, Satisfaction & Loyalty
Service Variability IndexTM (SVI)
Service Provider Differentiation
-
Functional Service Providers - Penetration, Strengths & Weaknesses
-
Perception Gap Analysis: Areas for Differentiation
Appendix of Charts and Graphs
About Industry Standard Research
For more information visit http://www.researchandmarkets.com/research/cfb25d/2009_cro_quality_b